Riva R - Search Results

1

Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease.

Contin M, Lopane G, Mohamed S, Calandra-Buonaura G, Capellari S, De Massis P, Nassetti S, Perrone A, Riva R, Sambati L, Scaglione C, Cortelli P. Contin M, et al. Among authors: riva r. Parkinsonism Relat Disord. 2019 Apr;61:111-117. doi: 10.1016/j.parkreldis.2018.11.007. Epub 2018 Nov 8. Parkinsonism Relat Disord. 2019. PMID: 30446407

2

Validated UHPLC-MS/MS method for the simultaneous determination of pramipexole and ropinirole in plasma of patients with Parkinson's disease.

Mohamed S, Riva R, Contin M. Mohamed S, et al. Among authors: riva r. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Apr 1;1017-1018:114-119. doi: 10.1016/j.jchromb.2016.02.041. Epub 2016 Mar 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26970845

3

Novel UHPLC-MS/MS method for the determination of rotigotine in the plasma of patients with Parkinson's disease.

Mohamed S, Riva R, Contin M. Mohamed S, et al. Among authors: riva r. Biomed Chromatogr. 2017 Sep;31(9). doi: 10.1002/bmc.3944. Epub 2017 Feb 20. Biomed Chromatogr. 2017. PMID: 28168729

4

Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.

Contin M, Martinelli P, Mochi M, Riva R, Albani F, Baruzzi A. Contin M, et al. Among authors: riva r. Mov Disord. 2005 Jun;20(6):734-9. doi: 10.1002/mds.20410. Mov Disord. 2005. PMID: 15747357 Clinical Trial.

5

The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease.

Contin M, Martinelli P, Scaglione C, Avoni P, Albani F, Riva R, Baruzzi A. Contin M, et al. Among authors: riva r. Clin Neuropharmacol. 2008 Sep-Oct;31(5):267-71. doi: 10.1097/WNF.0b013e31815c39aa. Clin Neuropharmacol. 2008. PMID: 18836344

6

Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy.

Contin M, Bisulli F, Santucci M, Riva R, Tonon F, Mohamed S, Ferri L, Stipa C, Tinuper P; Perampanel Study Group. Contin M, et al. Among authors: riva r. Epilepsia. 2018 Jul;59(7):e103-e108. doi: 10.1111/epi.14446. Epub 2018 Jun 13. Epilepsia. 2018. PMID: 29897632

7

Cerebrospinal Fluid Concentrations of Nimodipine Correlate With Long-term Outcome in Aneurysmal Subarachnoid Hemorrhage: Pilot Study.

Riva R, Pegoli M, Contin M, Perrone A, Mohamed S, Zanello M. Riva R, et al. Clin Neuropharmacol. 2019 Sep/Oct;42(5):157-162. doi: 10.1097/WNF.0000000000000356. Clin Neuropharmacol. 2019. PMID: 31306217

8

Development and Validation of an UHPLC-MS/MS Assay for the Therapeutic Monitoring of Brivaracetam Plasma Concentrations in Patients with Epilepsy.

Mohamed S, Riva R, Contin M. Mohamed S, et al. Among authors: riva r. Ther Drug Monit. 2020 Jun;42(3):445-451. doi: 10.1097/FTD.0000000000000726. Ther Drug Monit. 2020. PMID: 31934942

9

No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.

Contin M, Riva R, Martinelli P, Albani F, Baruzzi A. Contin M, et al. Among authors: riva r. Clin Neuropharmacol. 1992 Dec;15(6):505-8. doi: 10.1097/00002826-199212000-00008. Clin Neuropharmacol. 1992. PMID: 1477850

10

Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease.

Contin M, Riva R, Martinelli P, Albani F, Baruzzi A. Contin M, et al. Among authors: riva r. Eur J Clin Pharmacol. 1991;41(5):463-6. doi: 10.1007/BF00626370. Eur J Clin Pharmacol. 1991. PMID: 1761075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters